Concepedia

Arnab Chakravarti

AC

Statistics

Publications

73

Citations

11K

H-Index

40

Active since

1985

Affiliations

The Ohio State University(Current)

The University of Texas MD Anderson Cancer Center

Massachusetts General Hospital

University of Maryland, Baltimore

Harvard University

Arnab Chakravarti is an author at The Ohio State University specializing in oncology, medicine, and glioblastoma.

Publications per year

1985–2025

73

Publications

73

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert, James J. Dignam, Terri S. Armstrong et al. · New England Journal of Medicine · 2014 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

Mark R. Gilbert, Meihua Wang, Kenneth Aldape et al. · Journal of Clinical Oncology · 2013 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

Medicine, Oncology, Radiation Oncology +16

Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.

Arnab Chakravarti, Jay S. Loeffler, Nicholas J. Dyson · PubMed · 2002 · 513 citations

Medicine, Oncology, Pharmacology +17

An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Deliang Guo, Felicia Reinitz, Mary Youssef et al. · Cancer Discovery · 2011 · 447 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 73